Agentic Coding Collapses Build Costs. So Why Is Healthcare Software Still Hard?

In a previous piece, I argued that the real bottleneck in AI systems often lives at the interface between humans, workflows, and software rather than inside the model itself. Agentic coding pushes this shift even further. A few years ago, building serious software products in healthcare required sizable engineering organizations before you could even enter the conversation.

Today, that assumption is quietly breaking.

The Cost Curve Snapped

Small teams equipped with increasingly agentic development workflows can prototype sophisticated applications in days rather than months. Requirements become executable. Documentation, testing, integration scaffolding, and implementation loops increasingly collapse into the same accelerated pipeline.

The mechanics of software production are changing rapidly, and in many ways for the better. But there is a mistake hidden inside the current excitement around agentic coding: many people assume that if software becomes dramatically cheaper to build, success automatically becomes easier.

In regulated industries like healthcare, the opposite may happen.

Because the hard part did not disappear. It simply moved. When build costs collapse, competitive advantage migrates elsewhere: toward distribution, governance, workflow integration, trust, and operational reliability.

Cheap Build Does Not Mean Easy Success

Traditional software engineering largely optimized human implementation capacity: translating specifications through written code into execution.

Agentic workflows increasingly invert that relationship. The limiting factor becomes defining the right problem, constraining scope, and validating outputs.

The acceleration is not only in generation but also integration. Tool ecosystems and standardized interfaces increasingly reduce the friction of assembling complex systems. As generation and integration both accelerate, many people conclude that barriers to entry are disappearing altogether.

In regulated markets, that conclusion is often wrong.

A working demo is not market entry

In consumer software, a functional product may already be enough to test adoption. Healthcare operates differently.

A prototype is not deployment.

A deployment is not adoption.

And adoption is not operational trust.

The real barriers begin after the demo works.

Healthcare software is rarely evaluated as a standalone product. It is evaluated as part of a much larger operational system composed of procurement processes, interoperability constraints, clinical workflows, validation requirements, and organizational risk management.

In practice, this means the application itself is often the easiest part.

I have repeatedly seen technically impressive systems struggle not because the underlying capability was weak, but because integration into existing operational environments proved far harder than the original engineering effort.

The challenge was not simply building the software. It was earning the right to operate inside already complex systems.

The app is no longer the moat

As agentic systems reduce the cost of producing features, features themselves become less defensible.

Competitive pressure shifts elsewhere: toward workflow ownership, operational guarantees, embedded distribution, governance, and trust accumulated over time.

The moat increasingly stops being the application itself. It becomes the permission to operate.

Where The Barriers Reappear

Barrier #1 — Distribution

The best software in the world, however cheap, still loses if nobody encounters it inside their existing workflow.

I saw a similar dynamic years ago during the expansion of high-dimensional single-cell analysis. Tasks that previously required highly specialized scripting or manual analysis became increasingly automated and accessible.

But greater technical accessibility did not eliminate operational concerns. The question increasingly became not only: “Can the system do this?”, but: “Under what constraints is this system allowed to act?”

This creates a paradox: even as building software becomes easier, gaining meaningful access to users may become harder. The more I work in regulated environments, the less I believe software capability alone determines adoption.

Barrier #2 — Trust

Agentic systems introduce a new category of operational risk: autonomous or semi-autonomous execution inside critical environments.

In regulated environments, I’ve repeatedly seen technically impressive systems stall not because the underlying capability was weak, but because organizations could not operationalize trust around them.

The challenge was traceability, accountability, reproducibility, and integration into existing validation processes. Trust in healthcare is cumulative and asymmetrical. Reliability takes years to establish, while a single failure can destroy adoption.

In that context, autonomy is not merely a feature. It is a liability surface.

Barrier #3 — Workflow integration

One lesson I’ve learned repeatedly in enterprise healthcare environments is that technically functional software and operationally adoptable software are often completely different products.

One of the most persistent misconceptions in AI is that adoption is primarily a model problem. In practice, many failures occur much later, during operational integration.

Healthcare systems are extraordinarily complex environments composed of fragmented data flows, legacy infrastructures, overloaded users, and tightly coupled operational processes.

In healthcare, the last mile is often most of the work. Adoption frequently becomes a systems integration problem wearing an AI costume.

The New Moat

If software production becomes increasingly abundant, where does defensibility live? Increasingly, not in raw feature creation.

In regulated environments, competitive advantage starts accumulating around workflow ownership, operational trust, governance infrastructure, integration depth, and validated reliability over time.

Healthcare organizations rarely optimize for novelty alone. They optimize for continuity, accountability, and operational risk. This changes the competitive landscape significantly. The advantage shifts from:

“Who can build?”

to:

“Who can safely operate at scale?”

Paradoxically, cheaper software creation may strengthen some incumbents rather than weaken them, because distribution, trust, and workflow ownership become even more important once feature creation commoditizes.

Build Is Becoming Abundant

Agentic coding represents a genuine structural shift in software creation.

Small teams can now produce capabilities that previously required far larger organizations. The economics of software production are changing rapidly. But in healthcare and other regulated industries, cheaper software creation does not eliminate barriers to entry.

It relocates them. Toward trust. Toward workflow ownership. Toward governance, operational integration, and accumulated evidence over time. The more software creation becomes abundant, the more operational credibility becomes scarce.

The app is no longer the moat.

Operating permission is.